US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi
Caplin Point Laboratories Limited has announced that the United States Food and Drug Administration (USFDA) had completed its GMP and PAI inspection of Caplin Steriles Limited's (a subsidiary of Caplin Point Laboratories Limited) Sterile Injectable site at Gummidipoondi between May 22nd to 31st.
Caplin Point Laboratories | 02/06/2023 | By Sudeep Soparkar | 772
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy